Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Cholecalciferol Supplementation in Chronic Kidney Disease Patients With Restless Leg Syndrome

NCT03063190 is registered in ClinicalTrials.gov with University of Sao Paulo General Hospital as lead sponsor.

NCT NCT03063190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03063190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Cholecalciferol Supplementation in Chronic Kidney Disease Patients With Restless Leg Syndrome
Lead sponsor
University of Sao Paulo General Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
March 31, 2022
Completion date
March 31, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adynamic bone disease, hyperparathyroidism, secondary, renal disease bone, renal disease, end stage, restless leg disorder, vitamin d deficiency